470 related articles for article (PubMed ID: 12880497)
1. Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?
Geller DA; Biederman J; Stewart SE; Mullin B; Farrell C; Wagner KD; Emslie G; Carpenter D
J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S19-29. PubMed ID: 12880497
[TBL] [Abstract][Full Text] [Related]
2. Paroxetine open-label treatment of pediatric outpatients with obsessive-compulsive disorder.
Rosenberg DR; Stewart CM; Fitzgerald KD; Tawile V; Carroll E
J Am Acad Child Adolesc Psychiatry; 1999 Sep; 38(9):1180-5. PubMed ID: 10504818
[TBL] [Abstract][Full Text] [Related]
3. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators.
Zohar J; Judge R
Br J Psychiatry; 1996 Oct; 169(4):468-74. PubMed ID: 8894198
[TBL] [Abstract][Full Text] [Related]
4. A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder.
Denys D; van der Wee N; van Megen HJ; Westenberg HG
J Clin Psychopharmacol; 2003 Dec; 23(6):568-75. PubMed ID: 14624187
[TBL] [Abstract][Full Text] [Related]
5. Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.
Geller DA; Wagner KD; Emslie G; Murphy T; Carpenter DJ; Wetherhold E; Perera P; Machin A; Gardiner C
J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1387-96. PubMed ID: 15502598
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study.
Mundo E; Bianchi L; Bellodi L
J Clin Psychopharmacol; 1997 Aug; 17(4):267-71. PubMed ID: 9241005
[TBL] [Abstract][Full Text] [Related]
7. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
[TBL] [Abstract][Full Text] [Related]
8. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder.
March JS; Franklin ME; Leonard H; Garcia A; Moore P; Freeman J; Foa E
Biol Psychiatry; 2007 Feb; 61(3):344-7. PubMed ID: 17241830
[TBL] [Abstract][Full Text] [Related]
9. Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine.
Hollander E; Allen A; Steiner M; Wheadon DE; Oakes R; Burnham DB;
J Clin Psychiatry; 2003 Sep; 64(9):1113-21. PubMed ID: 14628989
[TBL] [Abstract][Full Text] [Related]
10. Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse.
Hollander E; Stein DJ; Fineberg NA; Marteau F; Legault M
J Clin Psychiatry; 2010 Jun; 71(6):784-92. PubMed ID: 20492845
[TBL] [Abstract][Full Text] [Related]
11. Paroxetine in the treatment of obsessive-compulsive disorder: randomized, double-blind, placebo-controlled study in Japanese patients.
Kamijima K; Murasaki M; Asai M; Higuchi T; Nakajima T; Taga C; Matsunaga H
Psychiatry Clin Neurosci; 2004 Aug; 58(4):427-33. PubMed ID: 15298657
[TBL] [Abstract][Full Text] [Related]
12. Personality changes in adult subjects with major depressive disorder or obsessive-compulsive disorder treated with paroxetine.
Brody AL; Saxena S; Fairbanks LA; Alborzian S; Demaree HA; Maidment KM; Baxter LR
J Clin Psychiatry; 2000 May; 61(5):349-55. PubMed ID: 10847309
[TBL] [Abstract][Full Text] [Related]
13. Comorbidity of obsessive-compulsive disorder and attention-deficit/hyperactivity disorder in referred children and adolescents.
Masi G; Millepiedi S; Mucci M; Bertini N; Pfanner C; Arcangeli F
Compr Psychiatry; 2006; 47(1):42-7. PubMed ID: 16324901
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical characteristics and comorbidity in schizophrenia patients with and without obsessive-compulsive disorder: schizophrenic and OC symptoms in schizophrenia.
Poyurovsky M; Kriss V; Weisman G; Faragian S; Kurs R; Schneidman M; Fuchs C; Weizman A; Weizman R
J Clin Psychiatry; 2003 Nov; 64(11):1300-7. PubMed ID: 14658943
[TBL] [Abstract][Full Text] [Related]
15. Remission and Relapse Across Three Years in Pediatric Obsessive-Compulsive Disorder Following Evidence-Based Treatments.
Ivarsson T; Jensen S; Højgaard DRMA; Hybel KA; Torp NC; Melin K; Nissen JB; Weidle B; Thomsen PH; Dahl K; Skarphedinsson G
J Am Acad Child Adolesc Psychiatry; 2024 May; 63(5):519-527. PubMed ID: 38070870
[TBL] [Abstract][Full Text] [Related]
16. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.
McDougle CJ; Goodman WK; Leckman JF; Lee NC; Heninger GR; Price LH
Arch Gen Psychiatry; 1994 Apr; 51(4):302-8. PubMed ID: 8161290
[TBL] [Abstract][Full Text] [Related]
17. Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder.
Torp NC; Dahl K; Skarphedinsson G; Compton S; Thomsen PH; Weidle B; Hybel K; Valderhaug R; Melin K; Nissen JB; Ivarsson T
J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):200-207.e1. PubMed ID: 25721185
[TBL] [Abstract][Full Text] [Related]
18. A naturalistic exploratory study of the impact of demographic, phenotypic and comorbid features in pediatric obsessive-compulsive disorder.
Masi G; Millepiedi S; Perugi G; Pfanner C; Berloffa S; Pari C; Mucci M; Akiskal HS
Psychopathology; 2010; 43(2):69-78. PubMed ID: 20068377
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A
Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
[TBL] [Abstract][Full Text] [Related]
20. Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine.
Gilbert AR; Moore GJ; Keshavan MS; Paulson LA; Narula V; Mac Master FP; Stewart CM; Rosenberg DR
Arch Gen Psychiatry; 2000 May; 57(5):449-56. PubMed ID: 10807485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
